Yüklüyor......
Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment
While COVID‐19 convalescent plasma (CCP) efficacy is still under investigation in randomized controlled trials (RCT), CCP collections continue worldwide with largely variable criteria. Since it is well known that only a minority of patients develop high‐titer neutralizing antibodies (nAb), as assess...
Kaydedildi:
| Yayımlandı: | Eur J Haematol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250676/ https://ncbi.nlm.nih.gov/pubmed/33780551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13630 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|